Key facts
- This page summarizes Jerome Benedict Durso's Form 4 filing for Altimmune, Inc. (ALT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2026, 16:05.
Jerome Benedict Durso - 01 Apr 2026 Form 4 Insider Report for Altimmune, Inc. (ALT)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ALT
- Reported as of
- 01 Apr 2026
- Net transaction value
- +$47,100
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2026, 16:05:14 UTC
- Prior SEC filing
- 09 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Weaver, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jerome Benedict Durso filed Form 4 for Altimmune, Inc. (ALT) on 01 Apr 2026.
Change
- Previous filing in this sequence was filed on 09 Mar 2026.
- Current net transaction value: +$47,100.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001698665
Primary reporting owner
Durso Jerome Benedict
- Relationship
- President and CEO, Director
- Address
- 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG
- Signature
- /s/ Gregory Weaver, as Attorney-in-Fact
- Signature date
- 01 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALT
transaction
Common Stock, par value $0.0001
Purchase
- Transaction value
- $47,100
- Shares
- +15,000
- Change %
- +46%
- Price
- $3.14
- Shares after
- 47,500
- Date
- 01 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.